Clinical Trial Update: Dapagliflozin at Discharge on Hospital Heart Failure Readmission [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates whether starting dapagliflozin at hospital discharge reduces heart failure readmissions in patients with heart failure and diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure

Drugs mentioned

• Forxiga (dapagliflozin)

Snippet

Sponsor: Emory University | Conditions: Heart Failure, Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2023-03-29